February 2008

Topics covered in this issue include:1) A Need to Better Manage Use of CT Scans to Avoid Excess Cancer

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue:Millennium Pharmiceuticals, Inc.: Future Looking Bright After Record

A collection of cancer statistics and facts.

The Clinical Trials reported in this issue include:PHASE III:1) What Factors Predict Prognosis in Patients With Malignant Pleural Mesothelioma?

Articles in this issue include:1) South Korea: Is Intermittent Imatinib Therapy for Chronic Myelogenous Leukemia an Option?

1) Lenalidomide (Revlimid) has been granted orphan medicinal product designation by the European Commission (EC) for treatment

New research suggests that a common but controversial treatment for prostate cancer reduces long-term death rates without greatly boosting patients' risk of heart problems.

The American Society of Hematology (ASH) held its 49th AnnualMeeting at the Georgia World Congress Center in Atlanta in December. The following reports provide summary coverage of meeting highlights,primarily focusing upon notable research breakthroughs relatingto hematological malignancies.

This month we report from the American Society of Hematology's 49th Annual Meeting.